Shao Wei-Li's Form 4/A amendment
AmendedOmada Health, Inc. (OMDA) · filed Jun 24, 2026
- Accession no.
- 0001610717-26-000295
- Filed
- Jun 24, 2026
- Trade date
- Jun 12, 2026
- Filing delay
- 12 days
- Rule 10b5-1 plan
- Checked
- Original filed
- Jun 16, 2026
This filing lists 1 non-derivative transaction. Open-market sales total $69.6K. It was filed 12 days after the trade.
This amendment replaces 0001610717-26-000224 (filed Jun 16, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shao Wei-LiCIK 0002069137 | Officer (President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Common Stock | SSaleDisposed | −4,037 | $17.24F3 | −$69,597.88 | 316,790 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
- F2
This Form 4/A is being filed solely to correct the number of shares reported as sold on June 12, 2026, and the total number of shares beneficially owned. Due to an administrative error by the broker, the original Form 4 filing overstated the number of shares sold under the Reporting Person's 10b5-1 trading plan. This amendment corrects the error to reflect the actual number of shares sold and beneficially owned.
- F3
This transaction was executed in multiple trades at prices ranging from $17.10 to $17.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.